This November, the AMP Study (also known as HVTN 703/HPTN 081) will bring a fresh approach to HIV prevention research. The Phase 2B study is inspired by vaccine research, which seeks to arm the immune system to resist HIV infection — but it skips a step by directly giving HIV-negative people antibodies rather than using … Continue reading Will the AMP Study Set the Standard for Transgender Inclusion in HIV Prevention Research?